GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Equity-to-Asset

Q2M Biotech AG (HAM:QBI) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Q2M Biotech AG's Total Stockholders Equity for the quarter that ended in . 20 was €0.00 Mil. Q2M Biotech AG's Total Assets for the quarter that ended in . 20 was €0.00 Mil.

The historical rank and industry rank for Q2M Biotech AG's Equity-to-Asset or its related term are showing as below:

HAM:QBI's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

Q2M Biotech AG Equity-to-Asset Historical Data

The historical data trend for Q2M Biotech AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Equity-to-Asset Chart

Q2M Biotech AG Annual Data
Trend
Equity-to-Asset

Q2M Biotech AG Quarterly Data
Equity-to-Asset

Competitive Comparison of Q2M Biotech AG's Equity-to-Asset

For the Biotechnology subindustry, Q2M Biotech AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q2M Biotech AG's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's Equity-to-Asset falls into.



Q2M Biotech AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Q2M Biotech AG's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Q2M Biotech AG's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q2M Biotech AG  (HAM:QBI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Q2M Biotech AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines